Comera Life Sciences (CMRA) Short Interest Ratio & Short Volume → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CMRA Stock Alerts $0.03 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media Comera Life Sciences Short Interest DataCurrent Short Interest138,100 sharesPrevious Short Interest281,600 sharesChange Vs. Previous Month-50.96%Dollar Volume Sold Short$33,751.64Short Interest Ratio0.7 Days to CoverLast Record DateNovember 15, 2023Outstanding Shares30,740,000 sharesFloat Size5,800,000 sharesShort Percent of Float2.38%Today's Trading Volume1 sharesAverage Trading Volume20,555 sharesToday's Volume Vs. Average0% Short Selling Comera Life Sciences ? Sign up to receive the latest short interest report for Comera Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMRA Short Interest Over TimeCMRA Days to Cover Over TimeCMRA Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Comera Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2023138,100 shares $33,751.64 -51.0%2.4%0.7 $0.24 10/31/2023281,600 shares $83,072.00 +531.4%5.5%1.8 $0.30 10/15/202344,600 shares $13,692.20 +59.9%0.9%0.3 $0.31 9/30/202327,900 shares $8,132.85 +196.8%0.5%0.6 $0.29 9/15/20239,400 shares $3,760.00 +54.1%0.2%0.1 $0.40 8/31/20236,100 shares $2,661.43 -67.2%1.3%0.1 $0.44 Get the Latest News and Ratings for CMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/15/202318,600 shares $11,392.50 -57.5%0.2%0.3 $0.61 7/31/202343,800 shares $26,061.00 -33.3%0.6%0.7 $0.60 7/15/202365,700 shares $36,798.57 +6.3%0.8%1.1 $0.56 6/30/202361,800 shares $30,121.32 +30.9%0.8%1.1 $0.49 6/15/202347,200 shares $25,016.00 +20.4%0.6%3.3 $0.53 5/31/202339,200 shares $19,992.00 -12.3%0.5%2.5 $0.51 5/15/202344,700 shares $31,737.00 +5.4%0.5%2.8 $0.71 4/30/202342,400 shares $31,032.56 -8.4%0.5%2.4 $0.73 4/15/202346,300 shares $37,966.00 -28.9%0.6%1.8 $0.82 3/31/202365,100 shares $58,524.90 -4.4%1.0%1.3 $0.90 3/15/202368,100 shares $76,272.00 +23.4%1.0%1.2 $1.12 2/28/202355,200 shares $67,896.00 -19.1%0.9%1 $1.23 2/15/202368,200 shares $90,706.00 -27.3%1.1%1.2 $1.33 1/31/202393,800 shares $127,568.00 -12.0%1.4%1.5 $1.36 1/15/2023106,600 shares $172,692.00 -39.0%1.6%1.5 $1.62 12/30/2022174,600 shares $214,758.00 -11.6%1.8%2.3 $1.23 12/15/2022197,600 shares $237,120.00 -4.2%2.0%2 $1.20 11/30/2022206,200 shares $315,486.00 -8.2%2.2%0.1 $1.53 11/15/2022224,500 shares $307,565.00 -18.1%2.4%0.1 $1.37 10/31/2022274,200 shares $408,558.00 +58.5%3.1%0.2 $1.49 10/15/2022173,000 shares $273,461.10 -28.8%1.4%0.1 $1.58 9/30/2022242,800 shares $390,908.00 -59.8%2.0%0.1 $1.61 9/15/2022604,600 shares $2.16 million +531.8%4.9%0.2 $3.57 8/31/202295,700 shares $169,389.00 -39.0%0.7%0 $1.77 8/15/2022156,800 shares $439,040.00 -84.8%1.1%0 $2.80 7/31/20221,030,000 shares $4.05 million +2,199.1%7.1%0.3 $3.93 7/15/202244,800 shares $92,288.00 No Change0.3%0 $2.06 CMRA Short Interest - Frequently Asked Questions What is Comera Life Sciences' current short interest? Short interest is the volume of Comera Life Sciences shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 138,100 shares of CMRA short. 2.38% of Comera Life Sciences' shares are currently sold short. Learn More on Comera Life Sciences' current short interest. What is a good short interest ratio for Comera Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMRA shares currently have a short interest ratio of 1.0. Learn More on Comera Life Sciences's short interest ratio. What is a good short interest percentage for Comera Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.38% of Comera Life Sciences' floating shares are currently sold short. Is Comera Life Sciences' short interest increasing or decreasing? Comera Life Sciences saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 138,100 shares, a drop of 51.0% from the previous total of 281,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Comera Life Sciences' float size? Comera Life Sciences currently has issued a total of 30,740,000 shares. Some of Comera Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Comera Life Sciences currently has a public float of 5,800,000 shares. How does Comera Life Sciences' short interest compare to its competitors? 2.38% of Comera Life Sciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Comera Life Sciences: Aditxt, Inc. (8.48%), China SXT Pharmaceuticals, Inc. (2.63%), SciSparc Ltd. (4.18%), Sunshine Biopharma, Inc. (29.84%), Aptevo Therapeutics Inc. (16.76%), Evelo Biosciences, Inc. (2.11%), Lucy Scientific Discovery Inc. (3.32%), GRI Bio, Inc. (0.46%), NeuBase Therapeutics, Inc. (0.51%), Biodexa Pharmaceuticals Plc (160.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Comera Life Sciences stock? Short selling CMRA is an investing strategy that aims to generate trading profit from Comera Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Comera Life Sciences? A short squeeze for Comera Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMRA, which in turn drives the price of the stock up even further. How often is Comera Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMRA, twice per month. The most recent reporting period available is November, 15 2023. More Short Interest Resources from MarketBeat Related Companies: Aditxt Short Interest Data China SXT Pharmaceuticals Short Interest Data SciSparc Short Interest Data Sunshine Biopharma Short Interest Data Aptevo Therapeutics Short Interest Data Evelo Biosciences Short Interest Data Lucy Scientific Discovery Short Interest Data GRI Bio Short Interest Data NeuBase Therapeutics Short Interest Data Biodexa Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMRA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 Cryptos BETTER than BitcoinTrue Market InsidersNext President (Not Trump. Not Biden.)The Freeport SocietyWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock Digest